×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DXCM – dexcom, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DXCM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/16
07:02 pm
dxcm
DexCom Stock Declines Following Strong Preliminary Q4 Results [Yahoo! Finance]
Low
Report
DexCom Stock Declines Following Strong Preliminary Q4 Results [Yahoo! Finance]
1/15
12:06 pm
dxcm
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
1/14
11:21 am
dxcm
DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025 [Yahoo! Finance]
Low
Report
DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025 [Yahoo! Finance]
1/13
11:46 pm
dxcm
How Investors May Respond To DexCom (DXCM) Strong 2025 Revenue Beat And 2026 Growth Outlook [Yahoo! Finance]
Low
Report
How Investors May Respond To DexCom (DXCM) Strong 2025 Revenue Beat And 2026 Growth Outlook [Yahoo! Finance]
1/13
07:46 pm
dxcm
Is DexCom (DXCM) Pricing Justified After Recent Multi Year Share Price Weakness [Yahoo! Finance]
Low
Report
Is DexCom (DXCM) Pricing Justified After Recent Multi Year Share Price Weakness [Yahoo! Finance]
1/13
05:11 pm
dxcm
Watch CNBC's exclusive interview with Dexcom CEO Jake Leach [CNBC]
Low
Report
Watch CNBC's exclusive interview with Dexcom CEO Jake Leach [CNBC]
1/13
08:01 am
dxcm
JPM26: Dexcom's new CEO eyes international CGM markets for 2026 growth [Yahoo! Finance]
Low
Report
JPM26: Dexcom's new CEO eyes international CGM markets for 2026 growth [Yahoo! Finance]
1/12
12:02 pm
dxcm
DexCom (NASDAQ:DXCM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
DexCom (NASDAQ:DXCM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
07:31 am
dxcm
Form 8-K DEXCOM INC For: Jan 07
Medium
Report
Form 8-K DEXCOM INC For: Jan 07
12/22
04:35 pm
dxcm
Form 8-K DEXCOM INC For: Dec 19
Low
Report
Form 8-K DEXCOM INC For: Dec 19
11/17
05:52 pm
dxcm
Form 4 DEXCOM INC For: Nov 14 Filed by: Collins Richard Alexander
Medium
Report
Form 4 DEXCOM INC For: Nov 14 Filed by: Collins Richard Alexander
11/14
09:50 am
dxcm
Form 144 DEXCOM INC Filed by: Collins Richard Alexander
Low
Report
Form 144 DEXCOM INC Filed by: Collins Richard Alexander
11/12
05:14 pm
dxcm
Form 4 DEXCOM INC For: Nov 12 Filed by: Heller Bridgette P
Low
Report
Form 4 DEXCOM INC For: Nov 12 Filed by: Heller Bridgette P
11/12
10:53 am
dxcm
Form 144 DEXCOM INC Filed by: Heller Bridgette P
Low
Report
Form 144 DEXCOM INC Filed by: Heller Bridgette P
11/10
07:13 pm
dxcm
Form 4 DEXCOM INC For: Nov 10 Filed by: Leach Jacob Steven
Medium
Report
Form 4 DEXCOM INC For: Nov 10 Filed by: Leach Jacob Steven
11/10
07:12 pm
dxcm
Form 4 DEXCOM INC For: Nov 10 Filed by: Collins Richard Alexander
Medium
Report
Form 4 DEXCOM INC For: Nov 10 Filed by: Collins Richard Alexander
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
Q3/2019 9/30/2019 EPS 0.650 ZacksConsensus 0.200 ActVsEst 0.450 - Beat
27.2%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
2/13 Q4/2019 12/31/2019 EPS 1.150 ZacksConsensus 0.750 ActVsEst 0.400 - Beat 12.0%
4/28 Q1/2020 3/31/2020 EPS 0.440 ZacksConsensus 0.100 ActVsEst 0.340 - Beat 10.3%
4/8 Form 4 DEXCOM INC For: Apr 07 Filed by: SAYER KEVIN R 7.9%
4/15 Top-Ranked Medical Duo Breaks Out — But Only One Holds Onto Its Gain [Investor's Business Daily] 4.9%
4/1 Form 4 DEXCOM INC For: Mar 30 Filed by: Selvaraj Shelly Ramasamy 4.9%
6/11 Form 4 DEXCOM INC For: Jun 10 Filed by: SAYER KEVIN R 4.9%
3/9 Form 4 DEXCOM INC For: Mar 05 Filed by: Pacelli Steven Robert 4.8%
2/14 IBD 50 Watchlist Of Growth Stocks Adds Nvidia, Tradeweb, Veeva, Wex [Investor's Business Daily] 4.6%
3/25 Form 4 DEXCOM INC For: Mar 13 Filed by: DOUBLEDAY RICHARD 4.5%
TOP News Decliners
3/14
Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep Vertex, Biogen, Dexcom, Eli Lilly, Masimo Under Observation [Investor's Business Daily]
-15.6%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
3/10 Form 8-K DEXCOM INC For: Mar 10 -9.6%
9/7 DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -9.4%
8/1 DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Robert W. Baird from $180.00 to $186.00. They now have an "outperform" rating on the stock. -7.5%
4/27 DexCom Q1 2020 Earnings Preview [Seeking Alpha] -7.0%
10/8 Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM -5.9%
3/19 Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) [Yahoo! Finance News] -5.4%
7/2 Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time -4.6%
9/5 Form 4 DEXCOM INC For: Sep 03 Filed by: Balo Andrew K -4.4%
2/20 Form 4 DEXCOM INC For: Feb 18 Filed by: Collins Richard Alexander -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: